Technicals — Closed at $307.44, just 3.2% above the 52-week low of $297.82. RSI(14) at 27.0 and RSI7 at 15.4 are deeply oversold, but the moving-average structure is uniformly bearish: price sits 19% below the 20-day ($380), 23% below the 50-day ($397) and 26% below the 200-day ($413), with all three fanning downward — the signature of a trending decline, not an oversold bounce setup. Down 17.2% on the week and 32.8% YTD. ATR of $17.9 is about 5.8% of spot. Extreme oversold readings in a downtrend typically deliver only technical rebounds; $297.82 is the line that must hold, with no prior support beneath it.
Fundamentals — The Q2 print is the root of this decline: non-GAAP EPS of $0.33 versus $0.5367 expected, a 38.5% miss; operating margin compressed to 1.4% as operating expenses jumped 47% year-over-year to $4.35 billion; free cash flow swung to negative $1.09 billion. Notably, deliveries and revenue set records — the problem is cost, meaning scale is no longer converting into profit and unit economics are deteriorating. The 285.6x multiple rests on option value from Robotaxi and FSD, and this quarter weakened the market's willingness to pay a premium for that option.
News — The stock fell nearly 15% the session after earnings and has bled lower since, closing down again on July 28 at a 26-week low, with an analyst downgrade adding pressure. Attention has shifted to the $299 area, widely framed as the line in the sand heading into the Fed decision. At the same time, a prominent analyst still projects 85% upside over twelve months — the bull/bear gap is unusually wide. The 53-analyst average target of $382.53 implies 24.4% upside, though that consensus likely has not fully absorbed the Q2 margin deterioration.
Holding last period's neutral (staying flat). RSI7 at 15.4 does raise the odds of a technical bounce, but a fully bearish moving-average structure plus deteriorating fundamentals (1.4% operating margin, negative FCF) leave any rally without fundamental support — going long here is a counter-trend bet with poor odds. Equally, a 285x multiple alongside a 32.8% YTD decline means multiple compression could still have room, yet with price hugging the 52-week low and tonight's Fed decision in play, shorting here is chasing weakness at the lows with unattractive risk/reward. Neither side has an edge, so staying flat is the only honest call — wait for $297.82 to break or for a high-volume reversal to set direction.
Long-term value hinges on whether Robotaxi and FSD can move from demonstration to commercial scale — the only narrative capable of supporting the current valuation. The vehicle business itself has entered a low-margin scale war, and a 1.4% operating margin shows that path cannot carry the multiple alone. Until autonomy delivers auditable revenue and unit economics, neutral is the only defensible long-term stance.
- Operating expenses up 47% year-over-year signal cost control risk
- Negative free cash flow could bring financing needs back
- A 285x multiple leaves zero tolerance for execution missteps
- Robotaxi regulatory and safety-incident risk is uncontrollable
- Chinese EV makers continue to compress share in global markets
- 07-07Long$419.77 → closed $380.8407-18-9.27%
- WSB · Mentions fell from 101 to 78 — the chatter is draining away, and real capitulation is when nobody talks about it anymore. Retail has left; what remains are the trapped and the not-yet-surrenderedOriginal ↗
- 华尔街共识 · 53 analysts average a $382.53 target, 24.4% above the $307.44 spot, with a 1.73 rating between Buy and Overweight — but most of that consensus predates the Q2 print and should be treated cautiously
- TradingKey · Flags $299 as the pivotal support into the Fed decision, with a break opening further downsideSource ↗
